Combined prevalence of type 2 diabetes and intermediate hyperglycaemia by trial arms and gender, age group and wealth tertile at the end of the study
| Characteristics | End-of-study diabetes and hyperglycaemia cases | |||||
| Control n (%) | mHealth n (%) | PLA n (%) | mHealth aOR (95% CI)* | PLA aOR (95% CI)* | ||
| Gender | Male | 799 (44.5) | 720 (41.6) | 455 (26.7) | 0.90 (0.71 to 1.13) p=0.347 | 0.42 (0.32 to 0.55) p<0.001* |
| Female | 1164 (57.5) | 1202 (58.2) | 703 (34.3) | 1.02 (0.77 to 1.35) p=0.887 | 0.33 (0.23 to 0.46) p<0.001* | |
| Age groups (years) | 30–39 | 590 (46.7) | 516 (44.8) | 329 (27.3) | 0.91 (0.70 to 1.19) p=0.504 | 0.33 (0.23 to 0.47) p<0.001* |
| 40–49 | 509 (46.5) | 512 (50.7) | 310 (21.0) | 1.06 (0.82 to 1.38) p=0.631 | 0.43 (0.31 to 0.59) p<0.001* | |
| 50–59 | 385 (54.8) | 445 (55.4) | 237 (32.1) | 1.03 (0.79 to 1.36) p=0.814 | 0.37 (0.28 to 0.51) p<0.001* | |
| ≥60 | 479 (57.9) | 449 (53.8) | 282 (34.8) | 0.87 (0.69 to 1.10) p=0.245 | 0.38 (0.28 to 0.51) p<0.001* | |
| Wealth tertiles | Most poor | 623 (55.0) | 661 (54.9) | 507 (34.2) | 0.98 (0.74 to 1.29) p=0.870 | 0.40 (0.29 to 0.56) p<0.001* |
| Poor | 610 (48.9) | 636 (48.5) | 300 (25.3) | 0.95 (0.74 to 1.21) p=0.669 | 0.32 (0.24 to 0.44) p<0.001* | |
| Least poor | 722 (51.7) | 616 (48.6) | 348 (32.3) | 0.89 (0.68 to 1.16) p=0.389 | 0.37 (0.27 to 0.51) p<0.001* | |
*Significant at p=0.003 after Bonferroni correction.
PLA, participatory learning and action.